Related references
Note: Only part of the references are listed.Acute exacerbation of interstitial lung disease associated with rheumatic disease
Fabrizio Luppi et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents
Vincenzo Venerito et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Steven R. Ytterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
Antonella Laria et al.
FRONTIERS IN MEDICINE (2022)
Methotrexate and rheumatoid arthritis associated interstitial, Lung disease
Pierre-Antoine Juge et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients Post Hoc Analysis From 21 Clinical Trials
Gustavo Citera et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Rheumatoid arthritis related interstitial lung disease
Andreina Manfredi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Liana Fraenkel et al.
ARTHRITIS CARE & RESEARCH (2021)
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
Caterina Vacchi et al.
CASE REPORTS IN MEDICINE (2021)
Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis
Annalisa Fui et al.
INTERNAL MEDICINE JOURNAL (2020)
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study
Andreina Manfredi et al.
INTERNAL MEDICINE JOURNAL (2020)
Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry
Cristina Vadillo et al.
RHEUMATOLOGY (2020)
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
Giulia Cassone et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Christopher R. Holroyd et al.
RHEUMATOLOGY (2019)
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
Andreina Manfredi et al.
JOURNAL OF THORACIC DISEASE (2019)
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
Vincenzo Venerito et al.
CLINICAL RHEUMATOLOGY (2019)
Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice
Sho Sendo et al.
ARTHRITIS RESEARCH & THERAPY (2019)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases
Roberto Perez-Alvarez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
J Ledingham et al.
RHEUMATOLOGY (2005)